Position in LYRA
as of Dec 31, 2025
· filed Feb 17, 2026
Position Value
$26,968
New position
Shares Held
8,756
first reported quarter
Ownership
0.493%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Artia Global Partners LP holds $357,221,619 across 38 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
628,712 | $102,806,986 | |
| 2 | ABVX |
Abivax S.A.
|
600,747 | $66,893,178 | |
| 3 | TRVI |
Trevi Therapeutics, Inc.
|
2,013,602 | $24,022,271 | |
| 4 | ARGX |
Argenx SE
|
29,739 | $21,716,904 | |
| 5 | NAMS |
NewAmsterdam Pharma Co N.V.
|
503,936 | $16,130,991 | |
| 6 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
162,990 | $13,678,120 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
124,990 | $12,155,277 | |
| 8 | IONS |
Ionis Pharmaceuticals Inc
|
144,376 | $10,841,193 |
All Filings in LYRA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2025-12-31 | $26,968 | 8,756 | Shares | Sole | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||